

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Rapid Identification of Malaria Vaccine Candidates Based on α-Helical Coiled Coil Protein Motif</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0000645"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0000645" />

    <meta name="citation_title" content="Rapid Identification of Malaria Vaccine Candidates Based on α-Helical Coiled Coil Protein Motif"/>
    <meta itemprop="name" content="Rapid Identification of Malaria Vaccine Candidates Based on α-Helical Coiled Coil Protein Motif"/>

      <meta name="citation_author" content="Viviane Villard"/>
            <meta name="citation_author_institution" content="Department of Biochemistry, University of Lausanne, Epalinges, Switzerland"/>
      <meta name="citation_author" content="George W. Agak"/>
            <meta name="citation_author_institution" content="Department of Biochemistry, University of Lausanne, Epalinges, Switzerland"/>
      <meta name="citation_author" content="Géraldine Frank"/>
            <meta name="citation_author_institution" content="Department of Biochemistry, University of Lausanne, Epalinges, Switzerland"/>
      <meta name="citation_author" content="Ali Jafarshad"/>
            <meta name="citation_author_institution" content="Pasteur Institute, Paris, France"/>
      <meta name="citation_author" content="Catherine Servis"/>
            <meta name="citation_author_institution" content="Department of Biochemistry, University of Lausanne, Epalinges, Switzerland"/>
      <meta name="citation_author" content="Issa Nébié"/>
            <meta name="citation_author_institution" content="Centre National de Recherche et Formation sur le Paludisme, Ouagadougou, Burkina Faso"/>
      <meta name="citation_author" content="Sodiomon B. Sirima"/>
            <meta name="citation_author_institution" content="Centre National de Recherche et Formation sur le Paludisme, Ouagadougou, Burkina Faso"/>
      <meta name="citation_author" content="Ingrid Felger"/>
            <meta name="citation_author_institution" content="Swiss Tropical Institute, Basel, Switzerland"/>
      <meta name="citation_author" content="Myriam Arevalo-Herrera"/>
            <meta name="citation_author_institution" content="Institute of Immunology, University of Valle, Cali, Colombia"/>
      <meta name="citation_author" content="Socrates Herrera"/>
            <meta name="citation_author_institution" content="Institute of Immunology, University of Valle, Cali, Colombia"/>
      <meta name="citation_author" content="Frederic Heitz"/>
            <meta name="citation_author_institution" content="CRBM, CNRS, University of Montpellier, Montpellier, France"/>
      <meta name="citation_author" content="Volker Bäcker"/>
            <meta name="citation_author_institution" content="CRBM, CNRS, University of Montpellier, Montpellier, France"/>
      <meta name="citation_author" content="Pierre Druilhe"/>
            <meta name="citation_author_institution" content="Pasteur Institute, Paris, France"/>
      <meta name="citation_author" content="Andrey V. Kajava"/>
            <meta name="citation_author_institution" content="CRBM, CNRS, University of Montpellier, Montpellier, France"/>
      <meta name="citation_author" content="Giampietro Corradin"/>
            <meta name="citation_author_institution" content="Department of Biochemistry, University of Lausanne, Epalinges, Switzerland"/>

    <meta name="citation_date" content="2007/7/25"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0000645.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e645"/>
    <meta name="citation_issue" content="7"/>
    <meta name="citation_volume" content="2"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.; citation_author=M Pizza; citation_author=V Scarlato; citation_author=V Masignani; citation_author=MM Giuliani; citation_author=B Arico; citation_journal_title=Science; citation_volume=287; citation_number=1; citation_pages=1816-1820; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Reverse vaccinology and genomics.; citation_author=R Rappuoli; citation_author=A Covacci; citation_journal_title=Science; citation_volume=302; citation_number=2; citation_pages=602; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants.; citation_author=DA Fidock; citation_author=H Gras-Masse; citation_author=JP Lepers; citation_author=K Brahimi; citation_author=L Benmohamed; citation_journal_title=J Immunol; citation_volume=153; citation_number=3; citation_pages=190-204; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3.; citation_author=P Daubersies; citation_author=AW Thomas; citation_author=P Millet; citation_author=K Brahimi; citation_author=JA Langermans; citation_journal_title=Nat Med; citation_volume=6; citation_number=4; citation_pages=1258-1263; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen.; citation_author=R Audran; citation_author=M Cachat; citation_author=F Lurati; citation_author=S Soe; citation_author=O Leroy; citation_journal_title=Infect Immun; citation_volume=73; citation_number=5; citation_pages=8017-8026; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Plasmodium falciparum merozoite surface protein 6 displays multiple targets for naturally occurring antibodies that mediate monocyte-dependent parasite killing.; citation_author=S Singh; citation_author=S Soe; citation_author=C Roussilhon; citation_author=G Corradin; citation_author=P Druilhe; citation_journal_title=Infect Immun; citation_volume=73; citation_number=6; citation_pages=1235-1238; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.; citation_author=B Tripet; citation_author=DJ Kao; citation_author=SA Jeffers; citation_author=KV Holmes; citation_author=RS Hodges; citation_journal_title=J Struct Biol; citation_volume=155; citation_number=7; citation_pages=176-194; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.; citation_author=JA Stoute; citation_author=J Gombe; citation_author=MR Withers; citation_author=J Siangla; citation_author=D McKinney; citation_journal_title=Vaccine; citation_number=8; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Boehringer Mannheim award lecture 1995. La conference Boehringer Mannheim 1995. De novo design of alpha-helical proteins: basic research to medical applications.; citation_author=RS Hodges; citation_journal_title=Biochem Cell Biol; citation_volume=74; citation_number=9; citation_pages=133-154; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Genome sequence of the human malaria parasite Plasmodium falciparum.; citation_author=MJ Gardner; citation_author=N Hall; citation_author=E Fung; citation_author=O White; citation_author=M Berriman; citation_journal_title=Nature; citation_volume=419; citation_number=10; citation_pages=498-511; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=A flexible motif search technique based on generalized profiles.; citation_author=P Bucher; citation_author=K Karplus; citation_author=N Moeri; citation_author=K Hofmann; citation_journal_title=Comput Chem; citation_volume=20; citation_number=11; citation_pages=3-23; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Transcriptomics and proteomics: tools for the identification of novel drug targets and vaccine candidates for tuberculosis.; citation_author=JC Betts; citation_journal_title=IUBMB Life; citation_volume=53; citation_number=12; citation_pages=239-242; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=A proteomic view of the Plasmodium falciparum life cycle.; citation_author=L Florens; citation_author=MP Washburn; citation_author=JD Raine; citation_author=RM Anthony; citation_author=M Grainger; citation_journal_title=Nature; citation_volume=419; citation_number=13; citation_pages=520-526; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum.; citation_author=Z Bozdech; citation_author=M Llinas; citation_author=BL Pulliam; citation_author=ED Wong; citation_author=J Zhu; citation_journal_title=PLoS Biol; citation_volume=1; citation_number=14; citation_pages=E5; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Crossreactive antigens between life cycle stages of plasmodium falciparum.; citation_author=I Moelans; citation_author=JG Schoenmakers; citation_journal_title=Parasitol Today; citation_volume=8; citation_number=15; citation_pages=118-123; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes.; citation_author=H Bouharoun-Tayoun; citation_author=P Attanath; citation_author=A Sabchareon; citation_author=T Chongsuphajaisiddhi; citation_author=P Druilhe; citation_journal_title=J Exp Med; citation_volume=172; citation_number=16; citation_pages=1633-1641; citation_date=1990; " />
      <meta name="citation_reference" content="citation_title=Mapping of conformational B cell epitopes within alpha-helical coiled coil proteins.; citation_author=JA Cooper; citation_author=W Hayman; citation_author=C Reed; citation_author=H Kagawa; citation_author=MF Good; citation_journal_title=Mol Immunol; citation_volume=34; citation_number=17; citation_pages=433-440; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=A de novo designed template for generating conformation-specific antibodies that recognize alpha-helices in proteins.; citation_author=SM Lu; citation_author=RS Hodges; citation_journal_title=J Biol Chem; citation_volume=277; citation_number=18; citation_pages=23515-23524; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Targeting malaria virulence and remodeling proteins to the host erythrocyte.; citation_author=M Marti; citation_author=RT Good; citation_author=M Rug; citation_author=E Knuepfer; citation_author=AF Cowman; citation_journal_title=Science; citation_volume=306; citation_number=19; citation_pages=1930-1933; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=A host-targeting signal in virulence proteins reveals a secretome in malarial infection.; citation_author=NL Hiller; citation_author=S Bhattacharjee; citation_author=C van Ooij; citation_author=K Liolios; citation_author=T Harrison; citation_journal_title=Science; citation_volume=306; citation_number=20; citation_pages=1934-1937; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Proteomic analysis identifies novel proteins of the Maurer's clefts, a secretory compartment delivering Plasmodium falciparum proteins to the surface of its host cell.; citation_author=L Vincensini; citation_author=S Richert; citation_author=T Blisnick; citation_author=A Van Dorsselaer; citation_author=E Leize-Wagner; citation_journal_title=Mol Cell Proteomics; citation_volume=4; citation_number=21; citation_pages=582-593; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Multi-character population study of the vir subtelomeric multigene superfamily of Plasmodium vivax, a major human malaria parasite.; citation_author=EF Merino; citation_author=C Fernandez-Becerra; citation_author=AM Durham; citation_author=JE Ferreira; citation_author=VF Tumilasci; citation_journal_title=Mol Biochem Parasitol; citation_volume=149; citation_number=22; citation_pages=10-16; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=A Maurer's cleft-associated protein is essential for expression of the major malaria virulence antigen on the surface of infected red blood cells.; citation_author=BM Cooke; citation_author=DW Buckingham; citation_author=FK Glenister; citation_author=KM Fernandez; citation_author=LH Bannister; citation_journal_title=J Cell Biol; citation_volume=172; citation_number=23; citation_pages=899-908; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII.; citation_author=A Jafarshad; citation_author=MH Dziegiel; citation_author=R Lundquist; citation_author=LK Nielsen; citation_author=S Singh; citation_journal_title=J Immunol; citation_volume=178; citation_number=24; citation_pages=3099-3106; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Predicting coiled coils from protein sequences.; citation_author=A Lupas; citation_author=M Van Dyke; citation_author=J Stock; citation_journal_title=Science; citation_volume=252; citation_number=25; citation_pages=1162-1164; citation_date=1991; " />
      <meta name="citation_reference" content="citation_title=Improved prediction of signal peptides: SignalP 3.0.; citation_author=JD Bendtsen; citation_author=H Nielsen; citation_author=G von Heijne; citation_author=S Brunak; citation_journal_title=J Mol Biol; citation_volume=340; citation_number=26; citation_pages=783-795; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=TMbase-A database of membrane spanning proteins segments.; citation_author=K Hofmann; citation_author=W Stoffel; citation_journal_title=Biol Chem Hoppe-Seyler 374; citation_number=27; citation_date=1993; " />
      <meta name="citation_reference" content="citation_title=Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.; citation_author=A Krogh; citation_author=B Larsson; citation_author=G von Heijne; citation_author=EL Sonnhammer; citation_journal_title=J Mol Biol; citation_volume=305; citation_number=28; citation_pages=567-580; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Prediction of potential GPI-modification sites in proprotein sequences.; citation_author=B Eisenhaber; citation_author=P Bork; citation_author=F Eisenhaber; citation_journal_title=J Mol Biol; citation_volume=292; citation_number=29; citation_pages=741-758; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=pTARGET [corrected] a new method for predicting protein subcellular localization in eukaryotes.; citation_author=C Guda; citation_author=S Subramaniam; citation_journal_title=Bioinformatics; citation_volume=21; citation_number=30; citation_pages=3963-3969; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data.; citation_author=A Bahl; citation_author=B Brunk; citation_author=J Crabtree; citation_author=MJ Fraunholz; citation_author=B Gajria; citation_journal_title=Nucleic Acids Res; citation_volume=31; citation_number=31; citation_pages=212-215; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=The Malaria Vaccine Epidemiology and Evaluation Project of Papua New Guinea: rationale and baseline studies.; citation_author=MP Alpers; citation_author=F al-Yaman; citation_author=HP Beck; citation_author=KK Bhatia; citation_author=J Hii; citation_journal_title=P N G Med J; citation_volume=35; citation_number=32; citation_pages=285-297; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies.; citation_author=JA Lopez; citation_author=C Weilenman; citation_author=R Audran; citation_author=MA Roggero; citation_author=A Bonelo; citation_journal_title=Eur J Immunol; citation_volume=31; citation_number=33; citation_pages=1989-1998; citation_date=2001; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000645" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Rapid Identification of Malaria Vaccine Candidates Based on α-Helical Coiled Coil Protein Motif"/>
    <meta name="twitter:description" content="To identify malaria antigens for vaccine development, we selected &alpha;-helical coiled coil domains of proteins predicted to be present in the parasite erythrocytic stage. The corresponding synthetic peptides are expected to mimic structurally &ldquo;native&rdquo; epitopes. Indeed the 95 chemically synthesized peptides were all specifically recognized by human immune sera, though at various prevalence. Peptide specific antibodies were obtained both by affinity-purification from malaria immune sera and by immunization of mice. These antibodies did not show significant cross reactions, i.e., they were specific for the original peptide, reacted with native parasite proteins in infected erythrocytes and several were active in inhibiting in vitro parasite growth. Circular dichroism studies indicated that the selected peptides assumed partial or high &alpha;-helical content. Thus, we demonstrate that the bioinformatics/chemical synthesis approach described here can lead to the rapid identification of molecules which target biologically active antibodies, thus identifying suitable vaccine candidates. This strategy can be, in principle, extended to vaccine discovery in a wide range of other pathogens."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0000645.g002"/>

  <meta property="og:title" content="Rapid Identification of Malaria Vaccine Candidates Based on α-Helical Coiled Coil Protein Motif" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000645" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=1903'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=4348'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=6970&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0000645">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000645" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000645&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Rapid Identification of Malaria Vaccine Candidates Based on α-Helical Coiled Coil Protein Motif
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Viviane Villard, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            George W. Agak, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Géraldine Frank, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Ali Jafarshad, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Pasteur Institute, Paris, France
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Catherine Servis, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Issa Nébié, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Centre National de Recherche et Formation sur le Paludisme, Ouagadougou, Burkina Faso
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Sodiomon B. Sirima, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Centre National de Recherche et Formation sur le Paludisme, Ouagadougou, Burkina Faso
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Ingrid Felger, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Swiss Tropical Institute, Basel, Switzerland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Myriam Arevalo-Herrera, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Institute of Immunology, University of Valle, Cali, Colombia
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Socrates Herrera, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Institute of Immunology, University of Valle, Cali, Colombia
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Frederic Heitz, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  CRBM, CNRS, University of Montpellier, Montpellier, France
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Volker Bäcker, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  CRBM, CNRS, University of Montpellier, Montpellier, France
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Pierre Druilhe, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Pasteur Institute, Paris, France
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Andrey V. Kajava, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  CRBM, CNRS, University of Montpellier, Montpellier, France
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Giampietro Corradin
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:giampietro.corradin@unil.ch">giampietro.corradin@unil.ch</a></p>

                <p>Affiliation:
                  Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: July 25, 2007</li>
    <li>DOI: 10.1371/journal.pone.0000645</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0000645" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0000645" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000645" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0000645" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0000645-t001" data-doi="info:doi/10.1371/journal.pone.0000645" data-uri="info:doi/10.1371/journal.pone.0000645.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000645-g001" data-doi="info:doi/10.1371/journal.pone.0000645" data-uri="info:doi/10.1371/journal.pone.0000645.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000645-t002" data-doi="info:doi/10.1371/journal.pone.0000645" data-uri="info:doi/10.1371/journal.pone.0000645.t002" title="Table 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000645-g002" data-doi="info:doi/10.1371/journal.pone.0000645" data-uri="info:doi/10.1371/journal.pone.0000645.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000645">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0000645" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1"></a><p>To identify malaria antigens for vaccine development, we selected α-helical coiled coil domains of proteins predicted to be present in the parasite erythrocytic stage. The corresponding synthetic peptides are expected to mimic structurally “native” epitopes. Indeed the 95 chemically synthesized peptides were all specifically recognized by human immune sera, though at various prevalence. Peptide specific antibodies were obtained both by affinity-purification from malaria immune sera and by immunization of mice. These antibodies did not show significant cross reactions, i.e., they were specific for the original peptide, reacted with native parasite proteins in infected erythrocytes and several were active in inhibiting <em>in vitro</em> parasite growth. Circular dichroism studies indicated that the selected peptides assumed partial or high α-helical content. Thus, we demonstrate that the bioinformatics/chemical synthesis approach described here can lead to the rapid identification of molecules which target biologically active antibodies, thus identifying suitable vaccine candidates. This strategy can be, in principle, extended to vaccine discovery in a wide range of other pathogens.</p>
</div>


<div class="articleinfo"><p><strong>Citation: </strong>Villard V, Agak GW, Frank G, Jafarshad A, Servis C, et al.  (2007) Rapid Identification of Malaria Vaccine Candidates Based on α-Helical Coiled Coil Protein Motif. PLoS ONE 2(7):
          e645.
            doi:10.1371/journal.pone.0000645</p><p><strong>Academic Editor: </strong>Allan Saul, National Institute of Allergy and Infectious Diseases, United States of America</p><p><strong>Received:</strong> December 20, 2006; <strong>Accepted:</strong> June 15, 2007; <strong>Published:</strong> July 25, 2007</p><p><strong>Copyright:</strong> © 2007 Villard et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>The work was supported by the Swiss National Science Foundation grant 310000-112244.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Human <em>Plasmodium falciparum</em> (<em>Pf</em>) infection is a dramatic public health problem. Today approximately forty percent of the world's population is at risk of malaria. Malaria causes more than 300 million acute clinical cases, and at least one million deaths annually. Ninety percent of malaria deaths occur in sub-Saharan African countries mostly among young children and pregnant women (<a href="http://rbm.who.int">http://rbm.who.int</a>). Thus, there is an urgent need of a malaria vaccine. However, vaccine discovery, in general and particularly in malaria, is still a very empirical process. In fact, protective antigens do not bear any structural, physico-chemical or sequence-related characteristics that would allow their identification. For protective humoral responses, the only recognized characteristics of antigens are their antigenicity/immunogenicity and accessibility. In addition, the lack of surrogate markers of protection renders the vaccine discovery process difficult and time consuming. Hence, in spite of a constant and impressive progress in molecular biology techniques and antigen identification and expression <a href="#pone.0000645-Pizza1">[1]</a>, <a href="#pone.0000645-Rappuoli1">[2]</a>, vaccine discovery is still labor-intensive, making the approach fastidious, costly and poorly adapted to high-throughput screening. Proper protein folding and solubility remain a limitation in numerous cases. Thus, overcoming the bottlenecks of manufacturing and identification of fragments/proteins, as possible targets of a protective immune response still constitute a scientific and technical challenge.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>We addressed this challenge by combining bioinformatics, chemical peptide synthesis and functional protection assays. We focused on the search for α-helical coiled coil motifs that, in general, do not exhibit a folding problem, and are a target of effective antibodies for several current malaria vaccine candidates (eg. LSA-1 <a href="#pone.0000645-Fidock1">[3]</a>, LSA-3 <a href="#pone.0000645-Daubersies1">[4]</a>, MSP-3 <a href="#pone.0000645-Audran1">[5]</a>, and MSP-6 <a href="#pone.0000645-Singh1">[6]</a> and other pathogens <a href="#pone.0000645-Tripet1">[7]</a>. MSP-1, another leading malaria vaccine <a href="#pone.0000645-Stoute1">[8]</a>, also contains predicted α-helical coiled coil regions (unpublished results). Our choice was based on the following considerations. First, the α-helical coiled coil motif bears a characteristic seven amino acid residue repeat (<strong>abcdefg</strong>)<sub>n</sub> with hydrophobic residues located in <strong>a</strong> and <strong>d</strong> positions and hydrophilic residues generally elsewhere. This motif can be easily identified by bioinformatic analysis. Secondly, an important known characteristic of the α-helical coiled coil domains is that, taken separately from the whole protein, they frequently and readily fold into the same stable oligomeric structure <a href="#pone.0000645-Hodges1">[9]</a>. Thirdly, for this reason, the α-helical coiled coil fragments are frequently recognized by conformational dependent antibodies, and can similarly elicit antibodies reactive with structurally “native” epitopes. In addition, these domains are short (about 40 residues) and can be rapidly produced by chemical synthesis. Furthermore, when the antibodies have an anti-parasite biological activity, this designates the corresponding proteins/fragments as potential, novel vaccine candidates to be further developed and assessed. Here, we focus on the <em>Pf</em> parasite erythrocytic stage, a target of protective antibodies and describe a straightforward, rapid procedure based on bioinformatic analysis of α-helical coiled-coil motifs and peptide synthesis.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Results and Discussion"></a><h3>Results and Discussion</h3><a id="article1.body1.sec2.p1" name="article1.body1.sec2.p1"></a><p>The screening of the <em>Pf</em> genome <a href="#pone.0000645-Gardner1">[10]</a> using generalized sequence profiles <a href="#pone.0000645-Bucher1">[11]</a> identified several hundred proteins containing putative α-helical coiled coil motifs. Through proteome and transcriptome data <a href="#pone.0000645-Betts1">[12]</a>–<a href="#pone.0000645-Bozdech1">[14]</a> we assessed which of these molecules are expressed in the <em>Pf</em> parasite erythrocytic stage. The combined analysis/assessment identified over 100 segments associated with this stage and displaying the putative α-helical coiled coil motifs with high probability score (<a href="#pone.0000645.s003">Table S1</a>). Out of these α-helical coiled coil fragments, in general 30–40 amino acids long, present either in the same protein or in different ones, 95 were chemically synthesized and HPLC purified. Among them, longer peptides (up to 70 amino acids), which contained one or more α-helical coiled coil domains, were also synthesized (antigenS 1, 12 and 83; <a href="#pone.0000645.s003">Table S1</a>). The selected antigens were then tested in ELISA assays for reactivity with three panels of sera obtained from adult donors from Burkina Faso, Tanzania and Colombia, respectively. To our surprise, all of the α-helical coiled coil fragments were antigenic, though the prevalence of responders varied greatly (<a href="#pone-0000645-t001">Tables 1</a> and <a href="#pone.0000645.s003">S1</a>). In this manner, 71 proteins were identified whose lengths varied from 200 to 10,000 amino acids. Twenty-one peptides with the highest prevalence of responders and ELISA mean OD value were selected for further studies. Variation in recognition among the three panels of sera may be due to differences in the genetic background of the hosts, of the parasites and, most likely, to distinct malaria transmission conditions in the three regions. The high level of recognition of the α-helical coiled coil motifs may be explained by the fact that taken separately from the whole protein these fragments readily fold into the same stable structure in aqueous solution.</p>
<div class="figure" id="pone-0000645-t001"><div class="img"><a name="pone-0000645-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000645" data-uri="info:doi/10.1371/journal.pone.0000645.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000645.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000645.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Antibody response and ADCI activity.</span></strong></p><span>doi:10.1371/journal.pone.0000645.t001</span></div><a id="article1.body1.sec2.p2" name="article1.body1.sec2.p2"></a><p>Indeed, circular dichroism (CD) studies of selected peptides associated with biological activities (<a href="#pone-0000645-t001">Tables 1</a> and <a href="#pone-0000645-t002">2</a>) indicate that they predominantly assume an α-helical conformation in water. Peptides 14, 27 and 45 (<a href="#pone.0000645.s001">Figure S1A</a>) exhibit a CD pattern characteristic of a high α-helical content, whereas the remaining peptides show CD profiles similar to that shown for peptide 12 (<a href="#pone.0000645.s001">Figure S1B</a>) or intermediate between those shown in Figures <a href="#pone.0000645.s001">S1A and S1B</a> characteristic of a partial α-helical organization. When analyzed by size exclusion chromatography on FPLC columns, peptides presented elution profiles between those exhibited by chymotrypsin and ribonuclease (MW 24 and 13kDa, respectively). The CD and size exclusion chromatography results suggest that peptides adopt an α-helical coiled-coil structure, which need to be unambiguously ascertained by NMR and ultra-centrifugation studies.</p>
<a id="article1.body1.sec2.p3" name="article1.body1.sec2.p3"></a><p>To test the biological activity of peptide-specific antibodies, the latter were purified by affinity chromatography using three serum pools obtained from Papua New Guinean adults. The 3 serum pools were first tested in ELISA assays against 21 peptides that were the most antigenic (<a href="#pone-0000645-t001">Table 1</a>); from these, 18 peptide-specific antibodies were purified from the most positive serum pool and tested again in ELISA. These 18 antibodies all reacted with parasite native proteins in infected red blood cells as shown by IFAT (<a href="#pone-0000645-g001">Figure 1A</a>; <a href="#pone-0000645-t002">Table 2</a>). Reactivity was restricted to blood stages, since the antibodies did not react with sporozoites stages (data not shown), and this reactivity was also peptide-specific as shown by IFAT competition assays with the corresponding peptide (<a href="#pone-0000645-g001">Figure 1A</a>).</p>
<div class="figure" id="pone-0000645-g001"><div class="img"><a name="pone-0000645-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000645" data-uri="info:doi/10.1371/journal.pone.0000645.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000645.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000645.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Immunofluorescence microscopy analysis of <em>Pf</em> 3D7 parasites with peptide specific antibodies.</span></strong></p><a id="article1.body1.sec2.fig1.caption1.p1" name="article1.body1.sec2.fig1.caption1.p1"></a><p>Acetone/methanol-fixed schizonts and merozoites were reacted with A: human peptide specific, affinity purified antibodies obtained with peptides 12 and 14 (<a href="#pone-0000645-t001">Table 1</a>) and B: sera from mice immunized with peptide 27 (<a href="#pone-0000645-t001">Table 1</a>). Grey: bright field images; blue staining: indicates DAPI nuclear staining of schizont stage parasites; red staining shows labeling of peptide specific antibodies by Cy3-conjugated anti-human or anti-mouse IgG specific antibody. Merge picture is an overlay of the blue and red fluorescence channel.</p>
<span>doi:10.1371/journal.pone.0000645.g001</span></div><div class="figure" id="pone-0000645-t002"><div class="img"><a name="pone-0000645-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000645" data-uri="info:doi/10.1371/journal.pone.0000645.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000645.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000645.t002.TIF"></span>)
                </a></li></ul></div><p><strong>Table 2.  <span>Summary data of human and mouse antibodies.</span></strong></p><span>doi:10.1371/journal.pone.0000645.t002</span></div><a id="article1.body1.sec2.p4" name="article1.body1.sec2.p4"></a><p>The specificity of the antibodies obtained was investigated in detail, particularly since several peptides contain glutamic acid (Glu)-rich sequences which are known to generate cross reactivity among several malarial Glu-rich proteins <a href="#pone.0000645-Moelans1">[15]</a>. Cross-reactions were systematically investigated using each of the 18 affinity-purified antibodies on each of the 18 peptides. Results show that -with few exceptions- each antibody preferentially recognizes the peptide against which antibodies were affinity-purified, i.e. they are specific for the corresponding peptide (<a href="#pone.0000645.s004">Table S2</a>). To determine if non-specific antibody binding to solid phase-adsorbed antigens could be responsible for the rare cross-reactivities detected, ELISA competition assays were performed. To this end, binding of antibodies to the solid phase-adsorbed antigen was competed against increasing concentrations of the homologous or cross-reacting peptides. Only homologous peptides competed best whereas peptides having sequence similarity did not (<a href="#pone-0000645-g002">Figures 2A, 2B</a>, and <a href="#pone.0000645.s002">S2B</a>), or at a much higher concentration (<a href="#pone.0000645.s002">Figure S2A</a>) including the shorter Glu-rich peptides derived from the C-terminus of peptide 27 and 45 (<a href="#pone-0000645-g002">Figures 2A and 2B</a>). Finally, the pattern of recognition of peptides by the various sera tested, which differ markedly from one to the other (data not shown), confirms the above results i.e., specificity of antibodies to the corresponding peptide.</p>
<div class="figure" id="pone-0000645-g002"><div class="img"><a name="pone-0000645-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000645" data-uri="info:doi/10.1371/journal.pone.0000645.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000645.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000645.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000645.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000645.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000645.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>ELISA inhibition assay using anti-human peptide specific antibodies.</span></strong></p><a id="article1.body1.sec2.fig2.caption1.p1" name="article1.body1.sec2.fig2.caption1.p1"></a><p>Binding of peptide specific antibodies to peptides 27 (A) and 45 (B) absorbed on ELISA plates was inhibited by incubating specific antibodies (1–2 µg/ml) with peptides 27 or 45 or shorter fragments of the two, designated as 27/short (NEEIEEIT) or 45/7 short (KEEIKE) (see <a href="#s3">Material and Methods</a>).</p>
<span>doi:10.1371/journal.pone.0000645.g002</span></div><a id="article1.body1.sec2.p5" name="article1.body1.sec2.p5"></a><p>Antibodies corresponding to the 18 selected peptides were tested for direct and cell-mediated anti-parasite activity. Clinical experiments have shown that the Antibody-Dependent Cell-mediated Inhibition (ADCI) of <em>P. falciparum</em> malaria represents one of the mechanisms controlling parasitemia and thereby clinical manifestations in humans <a href="#pone.0000645-BouharounTayoun1">[16]</a>. Twelve peptide-specific antibodies proved able to induce a strong (more than 40%) and intermediate (lower than 40%) monocyte-dependent parasite killing (<a href="#pone-0000645-t001">Table 1</a>), whereas, in the absence of monocytes, no direct effect of antibodies on parasite growth was observed. The effects were in the range observed with antibodies from African adults who have the highest natural protection known against malaria. Therefore peptide-specific, human affinity-purified antibodies were functionally effective as shown by their ability to react with parasite proteins and to inhibit parasite growth. Thus, <em>in vitro</em> functional assays show that peptide-specific antibodies elicited by natural exposure to the parasite can induce protective mechanisms effective against malaria.</p>
<a id="article1.body1.sec2.p6" name="article1.body1.sec2.p6"></a><p>Sixteen peptides -twelve targeted by ADCI positive antibodies and four controls-were used to immunize CB6F1 mice (<a href="#pone-0000645-t002">Table 2</a>). Eleven of them elicited an intermediate or high antibody response, four of which also recognized the parasite protein in infected erythrocytes as determined by IFAT (<a href="#pone-0000645-g001">Figure 1B</a>; <a href="#pone-0000645-t002">Table 2</a>). As seen before for human antibodies, recognition was restricted to blood stages since sporozoites were negative in IFAT assays (data not shown) and by IFAT competition assays with the corresponding peptide (<a href="#pone-0000645-g001">Figure 1B</a>). Anti-peptide 27 mouse antibodies, which are positive in IFAT, are also specific for the homologous peptide 27 but not for the sequence related peptides 9, 12 and 45 (<a href="#pone.0000645.s004">Table S2</a>). Thus, peptides, which were chosen for their propensity to form α-helical coiled coil, can induce the production of antibodies that recognize epitopes present in the native protein. Improvement of the immunogenicity and structural specificity of the remaining peptides might be achieved in the future by a) a short elongation at the N- and C- terminal ends, b) stabilizing the α-helix as suggested by Cooper et al. and Lu and Hodges <a href="#pone.0000645-Cooper1">[17]</a>, <a href="#pone.0000645-Lu1">[18]</a> and/or c) use of other adjuvants.</p>
<a id="article1.body1.sec2.p7" name="article1.body1.sec2.p7"></a><p>Genetic polymorphism in current vaccine candidates is a major limitation to vaccine development. However available genotyping studies of our peptide sequences in parasite isolates of worldwide origin indicate very limited polymorphism (PlasmoDB 5.2, and unpublished sequencing data). A few peptide DNA sequences show deletion of one entire heptad repeat so that the shorter region still preserves its potential for the α-helical coiled coil formation.</p>
<a id="article1.body1.sec2.p8" name="article1.body1.sec2.p8"></a><p>With regard to the structural features and cellular location prediction of the proteins corresponding to the peptides selected for ADCI assays (<a href="#pone-0000645-t001">Table 1</a>), 15 of the proteins contain a pentapeptide conforming to the PEXEL consensus [19, 20; 21, 22], but that none of these have a position within the amino acid sequence that conforms to the location of known active PEXEL motifs (see <a href="#s3">Materials and Methods</a> and <a href="#pone.0000645.s005">Table S3</a>); 12 have trans-membrane segments, and none of them has a GPI anchor. Only one protein contains a signal sequence. Fourteen proteins are predicted to be in the cytoplasm, one in the nucleus, one in the mitochondria, and one in the peroxysomes (<a href="#pone.0000645.s005">Table S3</a>). The prediction of the sub-cellular localization of these proteins should be taken with caution because gene annotation is being constantly updated and/or protein trafficking of the parasite is complex and not fully elucidated <a href="#pone.0000645-Cooke1">[23]</a>.</p>
<a id="article1.body1.sec2.p9" name="article1.body1.sec2.p9"></a><p>Further investigations will be required to determine the actual localization of the corresponding antigens. The predicted localization is a priori surprising for molecules able to trigger an ADCI activity. However, recent studies have shown that in addition to merozoite surface proteins, soluble proteins released at the time of schizont rupture were equally effective at triggering ADCI provided they defined at least two epitopes <a href="#pone.0000645-Jafarshad1">[24]</a>, which is the case for α-helical coiled coil heptad repeats. Therefore, molecules expressing a trans-membrane domain that can be exported to the parasite or host cell membrane, as well as molecules present in the cytoplasm of maturing schizonts and released by bursting schizonts can trigger antibodies to cross-link Fc-γ receptors on monocytes to achieve <em>Pf</em> parasite killing.</p>
<a id="article1.body1.sec2.p10" name="article1.body1.sec2.p10"></a><p>In conclusion, an approach combining a genome-wide search by bioinformatics of α-helical coiled coil protein motifs and chemical synthesis can lead to the rapid identification and development of new malaria vaccine candidates. In fact, this approach is straightforward and easy to scale up; vaccine formulations may comprise mixtures of peptides or single constructs made up of several epitopes. In principle, this strategy can be extended to the discovery of proteins and vaccine candidates in other complex pathogens.</p>
</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Bioinformatics screening</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>The <em>Pf</em> 3D7 genome <a href="#pone.0000645-Gardner1">[10]</a> was used for the bioinformatics analysis. The generalized sequence profile method and the pftools package <a href="#pone.0000645-Bucher1">[11]</a> were used to search for the short α-helical coiled coil domains. The coiled coil profiles were constructed using an alignment of several amino acid sequences corresponding to the known coiled coil domain. Two profiles containing four and five heptad repeats were used for the analysis. The cut-off levels of the profiles were chosen by tests performed against sequence database of proteins with the known 3D structures. Subsequently, the coiled coil regions selected by this approach were tested manually for the presence of the characteristic heptad repeats. These proteins were also analyzed by the COILS program <a href="#pone.0000645-Lupas1">[25]</a>.</p>
<a id="article1.body1.sec3.sec1.p2" name="article1.body1.sec3.sec1.p2"></a><p>The selected α-helical coiled coil containing proteins were further tested on their possible surface location and GPI anchoring by using the following programs: identification of potential signal peptides, SecretomeP and SignalP (<a href="http://www.cbs.dtu.dk/services/">http://www.cbs.dtu.dk/services/</a>) <a href="#pone.0000645-Bendtsen1">[26]</a>; transmembrane spanning regions (TMPRED <a href="http://www.ch.embnet.org/software/TMPRED_form.html">http://www.ch.embnet.org/software/TMPRED​_form.html</a> and TMHMM <a href="http://www.cbs.dtu.dk/services/TMHMM">http://www.cbs.dtu.dk/services/TMHMM</a>; <a href="#pone.0000645-Hofmann1">[27]</a>, <a href="#pone.0000645-Krogh1">[28]</a>), and GPI-anchored proteins (<a href="http://mendel.imp.univie.ac.at/sat/gpi/gpi_server.html">http://mendel.imp.univie.ac.at/sat/gpi/g​pi_server.html</a>; <a href="#pone.0000645-Eisenhaber1">[29]</a>) and prediction of sub-cellular localization (pTARGET <a href="http://bioinformatics.albany.edu/%E2%88%BCptarget">http://bioinformatics.albany.edu/~ptarge​t</a>; <a href="#pone.0000645-Guda1">[30]</a>). To identify the PEXEL-like motifs in sequences of the selected proteins we used the following pattern [KR][GAVLIMFWPSTCYNQ][LIA][GAVLIMFWPSTCY​NQ][DEQ] that represents a combination of the PEXEL patterns indicated in recent papers <a href="#pone.0000645-Vincensini1">[21]</a>, <a href="#pone.0000645-Merino1">[22]</a>. The presence of the identified proteins in the asexual erythrocytic stages was also checked using the published data on the transcriptome and proteome of this stage of development of <em>P. falciparum</em> (<a href="http://www.PlasmoDB.org">www.PlasmoDB.org</a>; <a href="#pone.0000645-Bahl1">[31]</a>).</p>


<h4>Peptide synthesis</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>Peptides were synthesized on the Advanced ChemTech (Hatley St George, UK) AC T348 Omega multi channel synthesizer and the Applied Biosystem synthesizer 431A and 433A (Foster City, CA) using solid-phase Fmoc chemistry. Crude peptides were purified by RP-HPLC (C18 preparative column) and analyzed by mass spectrometry (MALDI-TOF; Applied Biosystem, Foster City, CA). Chemicals and solvents used for peptide synthesis were purchased from Fluka (Buchs, Switzerland) and Novabiochem (Laufelfinger, Switzerland).</p>


<h4>Circular Dichroism Studies</h4>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1"></a><p>Circular dichroism (CD) spectra of peptides were recorded on a JASCO J-810 spectrometer (JASCO corporation, Tokyo, Japan) equipped with a temperature controller and a 0.1 cm path length cuvette. The measurements were made in water at pH 7.3 and 22°C and at a peptide concentration of 0.2 mg/ml.</p>


<h4>Human Sera</h4>
<a id="article1.body1.sec3.sec4.p1" name="article1.body1.sec3.sec4.p1"></a><p>The sera from Burkina Faso were collected in the village of Goundry located in the central Mossi Plateau, between 15 and 50 km north of the capital Ouagadougou, in the province of Oubritenga. The climate is characteristic of areas of Sudanese savannah, with a dry season from November to May and a rainy season from June to October. Malaria transmission is very high during the rainy season and markedly seasonal. Ethical clearance was obtained from the Ministry of Health, Burkina Faso. After obtaining informed consent from parents and caretakers, heparinized venous blood samples were collected during a cross-sectional survey during the malaria low transmission season 1998.</p>
<a id="article1.body1.sec3.sec4.p2" name="article1.body1.sec3.sec4.p2"></a><p>The Tanzanian sera came from a large-scale community based study undertaken in Kikwalila village, Kilombero District, Morogoro Region from 1982 to 1984. Blood samples from adults (&gt;15 years) were taken by finger prick and the serum was kept at –70°C until use. Research and ethical clearance for the study was obtained by the Tanzanian Commission for Science &amp; Technology.</p>
<a id="article1.body1.sec3.sec4.p3" name="article1.body1.sec3.sec4.p3"></a><p>The Colombian sera were collected in Buenaventura the main port on the Colombian Pacific Coast after human informed consent, during a cross sectional survey carried out from February to May 2002 within the framework of a project supported by the Colombian Research Council, COLCIENCIAS. The area has unstable transmission of both <em>P. falciparum</em> and <em>P. vivax</em> malaria. Ethical clearance to draw blood from human volunteers was obtained from the Institutional Review Board of Universidad del Valle. Blood was taken by venipuncture into tubes containing EDTA and sera fractionated and stored frozen until use.</p>
<a id="article1.body1.sec3.sec4.p4" name="article1.body1.sec3.sec4.p4"></a><p>The sera from adults from Papua New Guinea (PNG) pooled for affinity purification were collected in the Maprik district of the East Sepik Province, during a cross sectional survey in July 1992 within the framework of the Malaria vaccine Epidemiology and Evaluation Project (MVEEP) supported by the United States Agency for International Development <a href="#pone.0000645-Alpers1">[32]</a>. The area is highly endemic for malaria. Ethical clearance for MVEEP was obtained from the PNG Medical Research Advisory Committee. Blood was taken by venipuncture into tubes containing EDTA.</p>
<a id="article1.body1.sec3.sec4.p5" name="article1.body1.sec3.sec4.p5"></a><p>The pool of immune African globulins (PIAG) used for ADCI was prepared from immune individuals living in endemic areas and negative control IgG (N-IgG) was obtained from a pool of more than 1000 French adult donors with no history of malaria. Briefly, the IgG fractions from both positive and negative controls were purified using a size exclusion Trisacryl® GF05M (Pall BioSepra®; Pall life Sciences, NY) column followed by an ionic exchange DEAE Ceramic HyperD® F column (Pall BioSepra®). Purified IgG were then extensively dialyzed against RPMI and kept at 4°C until use.</p>


<h4>Mouse immunization</h4>
<a id="article1.body1.sec3.sec5.p1" name="article1.body1.sec3.sec5.p1"></a><p>CB6F1 mice were injected 3 times with 20 µg of the indicated peptide in Montanide ISA 720 at the base of the tail on day 1, 22 and 78. Bleeding was performed 10 days after the second and third immunization.</p>


<h4>ELISA</h4>
<a id="article1.body1.sec3.sec6.p1" name="article1.body1.sec3.sec6.p1"></a><p>ELISA was performed according to Lopez et al. <a href="#pone.0000645-Lopez1">[33]</a> and anti human IgG-or anti mouse IgG conjugated to alkaline phosphatase was used (Sigma, St Louis, MO) as second antibody. Individual human sera from 37, 42 and 39 adults donors from Burkina Faso, Tanzania and Colombia respectively were used at 1:200 dilution. Serum was considered positive if the optical density (OD) reading was higher than the mean OD value+3 standard deviation (SD) of the negative controls (individual serum samples from 8 to 11 naïve Swiss donors) or if the OD ratio of the mean of duplicate experimental values to the mean OD of the negative control was higher than 2. For mouse sera, the end point value was determined as the last dilution of the mean OD value+3 standard deviation (SD) of the negative control (non immune sera).</p>


<h4>ELISA Competition Assays</h4>
<a id="article1.body1.sec3.sec7.p1" name="article1.body1.sec3.sec7.p1"></a><p>ELISA competition assays were performed by incubating either each of the 18 selected human affinity-purified antibodies, or antibodies elicited in mice, together with each of the 18 antigens over the indicated range of concentrations for 30 minutes at room temperature prior to addition to the ELISA peptide-coated plate wells.</p>


<h4>Antibody Purification by Affinity Chromatography</h4>
<a id="article1.body1.sec3.sec8.p1" name="article1.body1.sec3.sec8.p1"></a><p>Antigen-Sepharose conjugate preparation: 5 mg of antigen was dissolved in 1 mL of coupling buffer (0.1 M NaHCO<sub>3</sub> containing 0.5 M NaCl, pH 8.0). The CNBr-sepharose 4B (Amersham Bioscience AB, Uppsala, Sweden) was activated by swelling in 1 mM HCl and then washed with coupling buffer. The antigen solution was added to the gel and the mixture was stirred for 1h at RT. After the coupling reaction, excess antigen was washed away with coupling buffer. The unreacted activated groups were blocked by treatment with ethanolamine (0.25 M; pH 8.0) for 30 min at RT. The gel was then washed with sodium acetate buffer (0.1 M; pH 4.0), followed by coupling buffer. The antigen-sepharose beads were either used or stored at 4°C in PBS (1x) containing 1 mM azide.</p>
<a id="article1.body1.sec3.sec8.p2" name="article1.body1.sec3.sec8.p2"></a><p>Isolation of specific antibody: Pooled human serum was diluted five times with PBS (1x) containing 0.5 M sodium chloride and mixed with antigen-sepharose conjugate. This mixture was then stirred gently on a wheel O/N at 4°C. After centrifugation the supernatant was collected and stored at −20°C for further use. The antigen-sepharose beads were then washed with 5 mL of trizma base TRIS (20 mM containing 0.5 M NaCl, pH 8.0) then with 5 mL of TRIS (20 mM, pH 8.0). The elution of bound antibody was achieved with glycine (0.1 M, pH 2.5). The fractions obtained were instantly neutralized with TRIS (1 M, pH 8.0), dialyzed against phosphate buffer (0.1M, pH 7.0) and the antibody concentration was determined by the absorbance of the solution at 280 nm.</p>


<h4>Indirect Fluorescence Antibody Test (IFAT)</h4>
<a id="article1.body1.sec3.sec9.p1" name="article1.body1.sec3.sec9.p1"></a><p>Slides coated with <em>Pf</em> sporozoites were dried at RT for 30 minutes, fixed with 100% acetone at 4°C for 10 minutes, washed 2 times in PBS-0.05% Tween 20, dried carefully and blocked with 20 µL/well of PBS-3% bovine serum albumin (BSA) for 30 minutes at RT. Slides coated with <em>Pf</em> merozoites were fixed with 100% acetone at −20°C for 15 minutes and dried O/N at RT. The appropriate antibody or serum dilutions prepared in PBS-3% BSA were distributed (10 µL/well) and incubated for 1h at RT in a humid chamber. After washing with PBS-0.05% Tween-20, goat anti-human or goat anti-mouse polyvalent immunoglobulins conjugated to Cy3 (Molecular Probes) diluted 1/500 in PBS-3% BSA or anti-human IgG (Fc specific) FITC conjugate (Sigma) diluted 1/50 in Evans blue solution (1/50000) was added (400 µL/slide) and incubated for 1h at RT in a humid chamber in the dark. Slides were washed as above, covered with 50 % glycerol, sealed and read using a fluorescence microscope (Leica DMIRB DC200).</p>


<h4>Parasites</h4>
<a id="article1.body1.sec3.sec10.p1" name="article1.body1.sec3.sec10.p1"></a><p>The Uganda Palo Alto strain (FUP/C) was cultured in RPMI-1640 supplemented with 0.5% albumax I (GibcoBRL-Invitrogen, San Diego, CA). For ADCI assays, blood stage parasite cultures were synchronized by at least two successive sorbitol treatments followed, after maturation over 24 h, by floatation on 1% porcine skin gelatin type A (Sigma).</p>


<h4>Preparation of human blood monocytes</h4>
<a id="article1.body1.sec3.sec11.p1" name="article1.body1.sec3.sec11.p1"></a><p>Blood monocytes (MN) were prepared from cytapheresis samples obtained from healthy blood donors with no previous history of malaria (Lecourbe Blood Bank, Paris, France). Peripheral blood mononuclear cells (PBMC) were separated on Ficoll density gradients J PREP (TechGen, Les Ulis, France) and washed in Ca<sup>2+</sup> and Mg<sup>2+</sup> free HBSS buffered with 10 mM HEPES (both from GibcoBRL-Invitrogen). Cells were then distributed on polystyrene 96-well flat-bottomed culture plates (TPP, Trasadingen, Switzerland) and adherent MN were selected by incubation for 2 h at 37°C, in a humidified 5% CO<sub>2</sub> atmosphere. More than 90% of the adherent cells obtained in this manner were MN as estimated by the non-specific esterase test (α-naphtyl acetate esterase; Sigma). MN from each donor were tested prior to ADCI assays and only those without direct inhibitory effect were used in assays.</p>


<h4>ADCI <em>in vitro</em> assay</h4>
<a id="article1.body1.sec3.sec12.p1" name="article1.body1.sec3.sec12.p1"></a><p>To wells containing 2×10<sup>5</sup> MN purified as described above, 50 µl of an asynchronous parasite culture at 0.5 % parasitemia and 4 % hematocrit were added. Wells were then supplemented with test or control antibodies (Ab) and the total volume adjusted to 100 µl with culture medium. After 48 h and 72 h, 50 µl of culture medium were added to each well and after 96 h the ADCI assay was stopped and the final parasitemia was determined by light microscopy on Giemsa-stained smears by counting ≥50,000 red blood cells. For each Ab tested, duplicate wells included the following controls 1) non-specific monocytic inhibition, both MN+parasite, and MN+N-IgG+parasites and 2) direct inhibition by control or test IgG, both N-IgG+parasites, and test Abs+parasites. PIAG and N-IgG were used at a final concentration of 1 mg/ml as positive and negative controls respectively. Immunopurified tests Abs were used at 15 µg/ml. The Specific Growth inhibitory Index (SGI) which considers the parasite growth inhibition due to the effect of test Abs cooperating with MN was calculated as follows: SGI = 100×[1−(% parasitemia with MN and test Abs/% parasitemia test Abs)/(% parasitemia with MN and N-IgG/% parasitemia N-IgG)].</p>

</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Supporting Information"></a><h3>Supporting Information</h3><div class="figshare_widget" doi="10.1371/journal.pone.0000645"></div><a name="pone.0000645.s001" id="pone.0000645.s001"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000645.s001">Figure S1. </a></strong></p><a id="article1.body1.sec4.supplementary-material1.caption1.p1" name="article1.body1.sec4.supplementary-material1.caption1.p1"></a><p class="preSiDOI">CD spectra of the peptides 45 (S1A) and 12 (S1B)</p>
<p class="siDoi">doi:10.1371/journal.pone.0000645.s001</p><a id="article1.body1.sec4.supplementary-material1.caption1.p2" name="article1.body1.sec4.supplementary-material1.caption1.p2"></a><p class="postSiDOI">(12.32 MB TIF)</p>
<a name="pone.0000645.s002" id="pone.0000645.s002"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000645.s002">Figure S2. </a></strong></p><a id="article1.body1.sec4.supplementary-material2.caption1.p1" name="article1.body1.sec4.supplementary-material2.caption1.p1"></a><p class="preSiDOI">ELISA inhibition assay using anti-human peptide specific antibodies. Binding of peptide specific antibodies to peptides 76 (S2A) and 9 (S2B) absorbed on ELISA plates was inhibited by incubating specific antibodies (1-2 µg/ml) with peptides 14, 76 and 81 (S2A) and peptides 8 and 9 (S2B), respectively (see <a href="#s3">Material and Methods</a>). Peptides 14, 76 and 79 share NNM or MNN as sequence similarity while peptides 8 and 9 do not exhibit any apparent sequence similarity.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000645.s002</p><a id="article1.body1.sec4.supplementary-material2.caption1.p2" name="article1.body1.sec4.supplementary-material2.caption1.p2"></a><p class="postSiDOI">(24.76 MB TIF)</p>
<a name="pone.0000645.s003" id="pone.0000645.s003"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000645.s003">Table S1. </a></strong></p><a id="article1.body1.sec4.supplementary-material3.caption1.p1" name="article1.body1.sec4.supplementary-material3.caption1.p1"></a><p class="preSiDOI">Antibody response.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000645.s003</p><a id="article1.body1.sec4.supplementary-material3.caption1.p2" name="article1.body1.sec4.supplementary-material3.caption1.p2"></a><p class="postSiDOI">(0.16 MB DOC)</p>
<a name="pone.0000645.s004" id="pone.0000645.s004"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000645.s004">Table S2. </a></strong></p><a id="article1.body1.sec4.supplementary-material4.caption1.p1" name="article1.body1.sec4.supplementary-material4.caption1.p1"></a><p class="preSiDOI">Cross-reactivity determination in ELISA among peptides tested in ADCI. The number in boxes represent the ratio between the experimental and control ELISA OD.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000645.s004</p><a id="article1.body1.sec4.supplementary-material4.caption1.p2" name="article1.body1.sec4.supplementary-material4.caption1.p2"></a><p class="postSiDOI">(0.36 MB DOC)</p>
<a name="pone.0000645.s005" id="pone.0000645.s005"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000645.s005">Table S3. </a></strong></p><a id="article1.body1.sec4.supplementary-material5.caption1.p1" name="article1.body1.sec4.supplementary-material5.caption1.p1"></a><p class="preSiDOI">Structural feature and cellular location prediction of the proteins containing the peptides whose specific antibodies were tested in ADCI (<a href="#pone-0000645-t001">Table 1</a>).</p>
<p class="siDoi">doi:10.1371/journal.pone.0000645.s005</p><a id="article1.body1.sec4.supplementary-material5.caption1.p2" name="article1.body1.sec4.supplementary-material5.caption1.p2"></a><p class="postSiDOI">(0.05 MB DOC)</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>The authors wish to thank Luis Rodrigues and Florela Penea for the synthesis and purification of peptides and Thomas Smith for discussion and all of the blood donors.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: GC VV GA VB AK AJ. Performed the experiments: VV GA GF VB AK AJ FH. Analyzed the data: GC VV GA GF VB AK AJ. Contributed reagents/materials/analysis tools: GC VV GA GF CS IN SS IF MA AJ SH. Wrote the paper: GC PD VV GA IN SS IF AK AJ SH.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0000645-Pizza1" id="pone.0000645-Pizza1"></a>Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, et al.  (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science  287: 1816–1820.  <ul class="find" data-citedArticleID="968888" data-doi="10.1126/science.287.5459.1816"><li><a href="http://dx.doi.org/10.1126/science.287.5459.1816" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Identification+of+vaccine+candidates+against+serogroup+B+meningococcus+by+whole-genome+sequencing." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Identification+of+vaccine+candidates+against+serogroup+B+meningococcus+by+whole-genome+sequencing.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0000645-Rappuoli1" id="pone.0000645-Rappuoli1"></a>Rappuoli R, Covacci A (2003) Reverse vaccinology and genomics. Science  302: 602.  <ul class="find" data-citedArticleID="968890" data-doi="10.1126/science.1092329"><li><a href="http://dx.doi.org/10.1126/science.1092329" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Reverse+vaccinology+and+genomics." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Reverse+vaccinology+and+genomics.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0000645-Fidock1" id="pone.0000645-Fidock1"></a>Fidock DA, Gras-Masse H, Lepers JP, Brahimi K, Benmohamed L, et al.  (1994) Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J Immunol  153: 190–204.  <ul class="find" data-citedArticleID="968858"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Plasmodium+falciparum+liver+stage+antigen-1+is+well+conserved+and+contains+potent+B+and+T+cell+determinants.&amp;auth=&amp;atitle=Plasmodium+falciparum+liver+stage+antigen-1+is+well+conserved+and+contains+potent+B+and+T+cell+determinants." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Plasmodium+falciparum+liver+stage+antigen-1+is+well+conserved+and+contains+potent+B+and+T+cell+determinants." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Plasmodium+falciparum+liver+stage+antigen-1+is+well+conserved+and+contains+potent+B+and+T+cell+determinants.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0000645-Daubersies1" id="pone.0000645-Daubersies1"></a>Daubersies P, Thomas AW, Millet P, Brahimi K, Langermans JA, et al.  (2000) Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat Med  6: 1258–1263.  <ul class="find" data-citedArticleID="968854"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Protection+against+Plasmodium+falciparum+malaria+in+chimpanzees+by+immunization+with+the+conserved+pre-erythrocytic+liver-stage+antigen+3.&amp;auth=&amp;atitle=Protection+against+Plasmodium+falciparum+malaria+in+chimpanzees+by+immunization+with+the+conserved+pre-erythrocytic+liver-stage+antigen+3." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Protection+against+Plasmodium+falciparum+malaria+in+chimpanzees+by+immunization+with+the+conserved+pre-erythrocytic+liver-stage+antigen+3." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Protection+against+Plasmodium+falciparum+malaria+in+chimpanzees+by+immunization+with+the+conserved+pre-erythrocytic+liver-stage+antigen+3.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0000645-Audran1" id="pone.0000645-Audran1"></a>Audran R, Cachat M, Lurati F, Soe S, Leroy O, et al.  (2005) Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen. Infect Immun  73: 8017–8026.  <ul class="find" data-citedArticleID="968836" data-doi="10.1128/iai.73.12.8017-8026.2005"><li><a href="http://dx.doi.org/10.1128/iai.73.12.8017-8026.2005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Phase+I+malaria+vaccine+trial+with+a+long+synthetic+peptide+derived+from+the+merozoite+surface+protein+3+antigen." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Phase+I+malaria+vaccine+trial+with+a+long+synthetic+peptide+derived+from+the+merozoite+surface+protein+3+antigen.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0000645-Singh1" id="pone.0000645-Singh1"></a>Singh S, Soe S, Roussilhon C, Corradin G, Druilhe P (2005) Plasmodium falciparum merozoite surface protein 6 displays multiple targets for naturally occurring antibodies that mediate monocyte-dependent parasite killing. Infect Immun  73: 1235–1238.  <ul class="find" data-citedArticleID="968892" data-doi="10.1128/iai.73.2.1235-1238.2005"><li><a href="http://dx.doi.org/10.1128/iai.73.2.1235-1238.2005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Plasmodium+falciparum+merozoite+surface+protein+6+displays+multiple+targets+for+naturally+occurring+antibodies+that+mediate+monocyte-dependent+parasite+killing." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Plasmodium+falciparum+merozoite+surface+protein+6+displays+multiple+targets+for+naturally+occurring+antibodies+that+mediate+monocyte-dependent+parasite+killing.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0000645-Tripet1" id="pone.0000645-Tripet1"></a>Tripet B, Kao DJ, Jeffers SA, Holmes KV, Hodges RS (2006) Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus. J Struct Biol  155: 176–194.  <ul class="find" data-citedArticleID="968896" data-doi="10.1016/j.jsb.2006.03.019"><li><a href="http://dx.doi.org/10.1016/j.jsb.2006.03.019" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Template-based+coiled-coil+antigens+elicit+neutralizing+antibodies+to+the+SARS-coronavirus." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Template-based+coiled-coil+antigens+elicit+neutralizing+antibodies+to+the+SARS-coronavirus.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0000645-Stoute1" id="pone.0000645-Stoute1"></a>Stoute JA, Gombe J, Withers MR, Siangla J, McKinney D, et al.  (2005) Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya. Vaccine.   <ul class="find" data-citedArticleID="968894" data-doi="10.1016/j.vaccine.2005.11.037"><li><a href="http://dx.doi.org/10.1016/j.vaccine.2005.11.037" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Phase+1+randomized+double-blind+safety+and+immunogenicity+trial+of+Plasmodium+falciparum+malaria+merozoite+surface+protein+FMP1+vaccine%2C+adjuvanted+with+AS02A%2C+in+adults+in+western+Kenya." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Phase+1+randomized+double-blind+safety+and+immunogenicity+trial+of+Plasmodium+falciparum+malaria+merozoite+surface+protein+FMP1+vaccine%2C+adjuvanted+with+AS02A%2C+in+adults+in+western+Kenya.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0000645-Hodges1" id="pone.0000645-Hodges1"></a>Hodges RS (1996) Boehringer Mannheim award lecture 1995. La conference Boehringer Mannheim 1995. De novo design of alpha-helical proteins: basic research to medical applications. Biochem Cell Biol  74: 133–154.  <ul class="find" data-citedArticleID="968868"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Boehringer+Mannheim+award+lecture+1995.+La+conference+Boehringer+Mannheim+1995.+De+novo+design+of+alpha-helical+proteins%3A+basic+research+to+medical+applications.&amp;auth=&amp;atitle=Boehringer+Mannheim+award+lecture+1995.+La+conference+Boehringer+Mannheim+1995.+De+novo+design+of+alpha-helical+proteins%3A+basic+research+to+medical+applications." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Boehringer+Mannheim+award+lecture+1995.+La+conference+Boehringer+Mannheim+1995.+De+novo+design+of+alpha-helical+proteins%3A+basic+research+to+medical+applications." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Boehringer+Mannheim+award+lecture+1995.+La+conference+Boehringer+Mannheim+1995.+De+novo+design+of+alpha-helical+proteins%3A+basic+research+to+medical+applications.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0000645-Gardner1" id="pone.0000645-Gardner1"></a>Gardner MJ, Hall N, Fung E, White O, Berriman M, et al.  (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature  419: 498–511.  <ul class="find" data-citedArticleID="968862" data-doi="10.1038/nature01097"><li><a href="http://dx.doi.org/10.1038/nature01097" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Genome+sequence+of+the+human+malaria+parasite+Plasmodium+falciparum." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Genome+sequence+of+the+human+malaria+parasite+Plasmodium+falciparum.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0000645-Bucher1" id="pone.0000645-Bucher1"></a>Bucher P, Karplus K, Moeri N, Hofmann K (1996) A flexible motif search technique based on generalized profiles. Comput Chem  20: 3–23.  <ul class="find" data-citedArticleID="968848" data-doi="10.1016/s0097-8485(96)80003-9"><li><a href="http://dx.doi.org/10.1016/s0097-8485(96)80003-9" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+flexible+motif+search+technique+based+on+generalized+profiles." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+flexible+motif+search+technique+based+on+generalized+profiles.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0000645-Betts1" id="pone.0000645-Betts1"></a>Betts JC (2002) Transcriptomics and proteomics: tools for the identification of novel drug targets and vaccine candidates for tuberculosis. IUBMB Life  53: 239–242.  <ul class="find" data-citedArticleID="968842" data-doi="10.1080/15216540212651"><li><a href="http://dx.doi.org/10.1080/15216540212651" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Transcriptomics+and+proteomics%3A+tools+for+the+identification+of+novel+drug+targets+and+vaccine+candidates+for+tuberculosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Transcriptomics+and+proteomics%3A+tools+for+the+identification+of+novel+drug+targets+and+vaccine+candidates+for+tuberculosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0000645-Florens1" id="pone.0000645-Florens1"></a>Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, et al.  (2002) A proteomic view of the Plasmodium falciparum life cycle. Nature  419: 520–526.  <ul class="find" data-citedArticleID="968860" data-doi="10.1038/nature01107"><li><a href="http://dx.doi.org/10.1038/nature01107" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+proteomic+view+of+the+Plasmodium+falciparum+life+cycle." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+proteomic+view+of+the+Plasmodium+falciparum+life+cycle.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0000645-Bozdech1" id="pone.0000645-Bozdech1"></a>Bozdech Z, Llinas M, Pulliam BL, Wong ED, Zhu J, et al.  (2003) The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum. PLoS Biol  1: E5.  <ul class="find" data-citedArticleID="968846" data-doi="10.1371/journal.pbio.0000005"><li><a href="http://dx.doi.org/10.1371/journal.pbio.0000005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+Transcriptome+of+the+Intraerythrocytic+Developmental+Cycle+of+Plasmodium+falciparum." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+Transcriptome+of+the+Intraerythrocytic+Developmental+Cycle+of+Plasmodium+falciparum.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0000645-Moelans1" id="pone.0000645-Moelans1"></a>Moelans I, Schoenmakers JG (1992) Crossreactive antigens between life cycle stages of plasmodium falciparum. Parasitol Today  8: 118–123.  <ul class="find" data-citedArticleID="968886" data-doi="10.1016/0169-4758(92)90278-a"><li><a href="http://dx.doi.org/10.1016/0169-4758(92)90278-a" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Crossreactive+antigens+between+life+cycle+stages+of+plasmodium+falciparum." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Crossreactive+antigens+between+life+cycle+stages+of+plasmodium+falciparum.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0000645-BouharounTayoun1" id="pone.0000645-BouharounTayoun1"></a>Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P (1990) Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med  172: 1633–1641.  <ul class="find" data-citedArticleID="968844" data-doi="10.1084/jem.172.6.1633"><li><a href="http://dx.doi.org/10.1084/jem.172.6.1633" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Antibodies+that+protect+humans+against+Plasmodium+falciparum+blood+stages+do+not+on+their+own+inhibit+parasite+growth+and+invasion+in+vitro%2C+but+act+in+cooperation+with+monocytes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Antibodies+that+protect+humans+against+Plasmodium+falciparum+blood+stages+do+not+on+their+own+inhibit+parasite+growth+and+invasion+in+vitro%2C+but+act+in+cooperation+with+monocytes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0000645-Cooper1" id="pone.0000645-Cooper1"></a>Cooper JA, Hayman W, Reed C, Kagawa H, Good MF, et al.  (1997) Mapping of conformational B cell epitopes within alpha-helical coiled coil proteins. Mol Immunol  34: 433–440.  <ul class="find" data-citedArticleID="968852" data-doi="10.1016/s0161-5890(97)00056-4"><li><a href="http://dx.doi.org/10.1016/s0161-5890(97)00056-4" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mapping+of+conformational+B+cell+epitopes+within+alpha-helical+coiled+coil+proteins." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mapping+of+conformational+B+cell+epitopes+within+alpha-helical+coiled+coil+proteins.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0000645-Lu1" id="pone.0000645-Lu1"></a>Lu SM, Hodges RS (2002) A de novo designed template for generating conformation-specific antibodies that recognize alpha-helices in proteins. J Biol Chem  277: 23515–23524.  <ul class="find" data-citedArticleID="968878" data-doi="10.1074/jbc.m201981200"><li><a href="http://dx.doi.org/10.1074/jbc.m201981200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+de+novo+designed+template+for+generating+conformation-specific+antibodies+that+recognize+alpha-helices+in+proteins." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+de+novo+designed+template+for+generating+conformation-specific+antibodies+that+recognize+alpha-helices+in+proteins.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0000645-Marti1" id="pone.0000645-Marti1"></a>Marti M, Good RT, Rug M, Knuepfer E, Cowman AF (2004) Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science  306: 1930–1933.  <ul class="find" data-citedArticleID="968882" data-doi="10.1126/science.1102452"><li><a href="http://dx.doi.org/10.1126/science.1102452" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Targeting+malaria+virulence+and+remodeling+proteins+to+the+host+erythrocyte." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Targeting+malaria+virulence+and+remodeling+proteins+to+the+host+erythrocyte.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0000645-Hiller1" id="pone.0000645-Hiller1"></a>Hiller NL, Bhattacharjee S, van Ooij C, Liolios K, Harrison T, et al.  (2004) A host-targeting signal in virulence proteins reveals a secretome in malarial infection. Science  306: 1934–1937.  <ul class="find" data-citedArticleID="968866" data-doi="10.1126/science.1102737"><li><a href="http://dx.doi.org/10.1126/science.1102737" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+host-targeting+signal+in+virulence+proteins+reveals+a+secretome+in+malarial+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+host-targeting+signal+in+virulence+proteins+reveals+a+secretome+in+malarial+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0000645-Vincensini1" id="pone.0000645-Vincensini1"></a>Vincensini L, Richert S, Blisnick T, Van Dorsselaer A, Leize-Wagner E, et al.  (2005) Proteomic analysis identifies novel proteins of the Maurer's clefts, a secretory compartment delivering Plasmodium falciparum proteins to the surface of its host cell. Mol Cell Proteomics  4: 582–593.  <ul class="find" data-citedArticleID="968898" data-doi="10.1074/mcp.m400176-mcp200"><li><a href="http://dx.doi.org/10.1074/mcp.m400176-mcp200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Proteomic+analysis+identifies+novel+proteins+of+the+Maurer%27s+clefts%2C+a+secretory+compartment+delivering+Plasmodium+falciparum+proteins+to+the+surface+of+its+host+cell." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Proteomic+analysis+identifies+novel+proteins+of+the+Maurer%27s+clefts%2C+a+secretory+compartment+delivering+Plasmodium+falciparum+proteins+to+the+surface+of+its+host+cell.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0000645-Merino1" id="pone.0000645-Merino1"></a>Merino EF, Fernandez-Becerra C, Durham AM, Ferreira JE, Tumilasci VF, et al.  (2006) Multi-character population study of the vir subtelomeric multigene superfamily of Plasmodium vivax, a major human malaria parasite. Mol Biochem Parasitol  149: 10–16.  <ul class="find" data-citedArticleID="968884" data-doi="10.1016/j.molbiopara.2006.04.002"><li><a href="http://dx.doi.org/10.1016/j.molbiopara.2006.04.002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Multi-character+population+study+of+the+vir+subtelomeric+multigene+superfamily+of+Plasmodium+vivax%2C+a+major+human+malaria+parasite." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Multi-character+population+study+of+the+vir+subtelomeric+multigene+superfamily+of+Plasmodium+vivax%2C+a+major+human+malaria+parasite.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0000645-Cooke1" id="pone.0000645-Cooke1"></a>Cooke BM, Buckingham DW, Glenister FK, Fernandez KM, Bannister LH, et al.  (2006) A Maurer's cleft-associated protein is essential for expression of the major malaria virulence antigen on the surface of infected red blood cells. J Cell Biol  172: 899–908.  <ul class="find" data-citedArticleID="968850" data-doi="10.1083/jcb.200509122"><li><a href="http://dx.doi.org/10.1083/jcb.200509122" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+Maurer%27s+cleft-associated+protein+is+essential+for+expression+of+the+major+malaria+virulence+antigen+on+the+surface+of+infected+red+blood+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+Maurer%27s+cleft-associated+protein+is+essential+for+expression+of+the+major+malaria+virulence+antigen+on+the+surface+of+infected+red+blood+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0000645-Jafarshad1" id="pone.0000645-Jafarshad1"></a>Jafarshad A, Dziegiel MH, Lundquist R, Nielsen LK, Singh S, et al.  (2007) A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. J Immunol  178: 3099–3106.  <ul class="find" data-citedArticleID="968872"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=A+novel+antibody-dependent+cellular+cytotoxicity+mechanism+involved+in+defense+against+malaria+requires+costimulation+of+monocytes+FcgammaRII+and+FcgammaRIII.&amp;auth=&amp;atitle=A+novel+antibody-dependent+cellular+cytotoxicity+mechanism+involved+in+defense+against+malaria+requires+costimulation+of+monocytes+FcgammaRII+and+FcgammaRIII." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+novel+antibody-dependent+cellular+cytotoxicity+mechanism+involved+in+defense+against+malaria+requires+costimulation+of+monocytes+FcgammaRII+and+FcgammaRIII." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+novel+antibody-dependent+cellular+cytotoxicity+mechanism+involved+in+defense+against+malaria+requires+costimulation+of+monocytes+FcgammaRII+and+FcgammaRIII.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0000645-Lupas1" id="pone.0000645-Lupas1"></a>Lupas A, Van Dyke M, Stock J (1991) Predicting coiled coils from protein sequences. Science  252: 1162–1164.  <ul class="find" data-citedArticleID="968880" data-doi="10.1126/science.252.5009.1162"><li><a href="http://dx.doi.org/10.1126/science.252.5009.1162" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Predicting+coiled+coils+from+protein+sequences." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Predicting+coiled+coils+from+protein+sequences.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0000645-Bendtsen1" id="pone.0000645-Bendtsen1"></a>Bendtsen JD, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol  340: 783–795.  <ul class="find" data-citedArticleID="968840" data-doi="10.1016/j.jmb.2004.05.028"><li><a href="http://dx.doi.org/10.1016/j.jmb.2004.05.028" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Improved+prediction+of+signal+peptides%3A+SignalP+3.0." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Improved+prediction+of+signal+peptides%3A+SignalP+3.0.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0000645-Hofmann1" id="pone.0000645-Hofmann1"></a>Hofmann K, Stoffel W (1993) TMbase-A database of membrane spanning proteins segments. Biol Chem Hoppe-Seyler 374.   <ul class="find" data-citedArticleID="968870"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=TMbase-A+database+of+membrane+spanning+proteins+segments.&amp;auth=&amp;atitle=TMbase-A+database+of+membrane+spanning+proteins+segments." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=TMbase-A+database+of+membrane+spanning+proteins+segments." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22TMbase-A+database+of+membrane+spanning+proteins+segments.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0000645-Krogh1" id="pone.0000645-Krogh1"></a>Krogh A, Larsson B, von Heijne G, Sonnhammer EL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol  305: 567–580.  <ul class="find" data-citedArticleID="968874" data-doi="10.1006/jmbi.2000.4315"><li><a href="http://dx.doi.org/10.1006/jmbi.2000.4315" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Predicting+transmembrane+protein+topology+with+a+hidden+Markov+model%3A+application+to+complete+genomes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Predicting+transmembrane+protein+topology+with+a+hidden+Markov+model%3A+application+to+complete+genomes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0000645-Eisenhaber1" id="pone.0000645-Eisenhaber1"></a>Eisenhaber B, Bork P, Eisenhaber F (1999) Prediction of potential GPI-modification sites in proprotein sequences. J Mol Biol  292: 741–758.  <ul class="find" data-citedArticleID="968856" data-doi="10.1006/jmbi.1999.3069"><li><a href="http://dx.doi.org/10.1006/jmbi.1999.3069" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Prediction+of+potential+GPI-modification+sites+in+proprotein+sequences." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Prediction+of+potential+GPI-modification+sites+in+proprotein+sequences.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0000645-Guda1" id="pone.0000645-Guda1"></a>Guda C, Subramaniam S (2005) pTARGET [corrected] a new method for predicting protein subcellular localization in eukaryotes. Bioinformatics  21: 3963–3969.  <ul class="find" data-citedArticleID="968864" data-doi="10.1093/bioinformatics/bti650"><li><a href="http://dx.doi.org/10.1093/bioinformatics/bti650" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=pTARGET+%5Bcorrected%5D+a+new+method+for+predicting+protein+subcellular+localization+in+eukaryotes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22pTARGET+%5Bcorrected%5D+a+new+method+for+predicting+protein+subcellular+localization+in+eukaryotes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0000645-Bahl1" id="pone.0000645-Bahl1"></a>Bahl A, Brunk B, Crabtree J, Fraunholz MJ, Gajria B, et al.  (2003) PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res  31: 212–215.  <ul class="find" data-citedArticleID="968838" data-doi="10.1093/nar/gkg081"><li><a href="http://dx.doi.org/10.1093/nar/gkg081" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=PlasmoDB%3A+the+Plasmodium+genome+resource.+A+database+integrating+experimental+and+computational+data." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22PlasmoDB%3A+the+Plasmodium+genome+resource.+A+database+integrating+experimental+and+computational+data.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0000645-Alpers1" id="pone.0000645-Alpers1"></a>Alpers MP, al-Yaman F, Beck HP, Bhatia KK, Hii J, et al.  (1992) The Malaria Vaccine Epidemiology and Evaluation Project of Papua New Guinea: rationale and baseline studies. P N G Med J  35: 285–297.  <ul class="find" data-citedArticleID="968834"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=The+Malaria+Vaccine+Epidemiology+and+Evaluation+Project+of+Papua+New+Guinea%3A+rationale+and+baseline+studies.&amp;auth=&amp;atitle=The+Malaria+Vaccine+Epidemiology+and+Evaluation+Project+of+Papua+New+Guinea%3A+rationale+and+baseline+studies." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+Malaria+Vaccine+Epidemiology+and+Evaluation+Project+of+Papua+New+Guinea%3A+rationale+and+baseline+studies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+Malaria+Vaccine+Epidemiology+and+Evaluation+Project+of+Papua+New+Guinea%3A+rationale+and+baseline+studies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0000645-Lopez1" id="pone.0000645-Lopez1"></a>Lopez JA, Weilenman C, Audran R, Roggero MA, Bonelo A, et al.  (2001) A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies. Eur J Immunol  31: 1989–1998.  <ul class="find" data-citedArticleID="968876" data-doi="10.1002/1521-4141(200107)31:7<1989::aid-immu1989&gt;3.0.co;2-m"><li><a href="http://dx.doi.org/10.1002/1521-4141(200107)31:7<1989::aid-immu1989&gt;3.0.co;2-m" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+synthetic+malaria+vaccine+elicits+a+potent+CD8%28%2B%29+and+CD4%28%2B%29+T+lymphocyte+immune+response+in+humans.+Implications+for+vaccination+strategies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+synthetic+malaria+vaccine+elicits+a+potent+CD8%28%2B%29+and+CD4%28%2B%29+T+lymphocyte+immune+response+in+humans.+Implications+for+vaccination+strategies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.XML" value="101539"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.PDF" value="185140"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.t001.PNG_L" value="402636"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.t001.PNG_M" value="154417"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.t001.PNG_S" value="14949"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.t001.TIF" value="1781890"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.t001.PNG_I" value="47301"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.g001.PNG_L" value="894873"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.g001.PNG_M" value="177121"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.g001.PNG_S" value="8854"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.g001.TIF" value="1230974"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.g001.PNG_I" value="58966"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.t002.PNG_L" value="163827"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.t002.PNG_M" value="95408"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.t002.PNG_S" value="13173"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.t002.TIF" value="808408"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.t002.PNG_I" value="29539"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.g002.PNG_L" value="274957"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.g002.PNG_M" value="85763"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.g002.PNG_S" value="9399"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.g002.TIF" value="430760"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.g002.PNG_I" value="43992"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.s001.TIF" value="12320135"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.s002.TIF" value="24761424"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.s003.DOC" value="159744"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.s004.DOC" value="358912"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000645.s005.DOC" value="49664"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000645&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000645" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000645&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0000645&volume=&issue=&title=Rapid Identification of Malaria Vaccine Candidates Based on α-Helical Coiled Coil Protein Motif&author_name=Viviane%20Villard%2C%20George%20W.%20Agak%2C%20G%C3%A9raldine%20Frank%2C%20Ali%20Jafarshad%2C%20Catherine%20Servis%2C%20Issa%20N%C3%A9bi%C3%A9%2C%20Sodiomon%20B.%20Sirima%2C%20Ingrid%20Felger%2C%20Myriam%20Arevalo-Herrera%2C%20Socrates%20Herrera%2C%20Frederic%20Heitz%2C%20Volker%20B%C3%A4cker%2C%20Pierre%20Druilhe%2C%20Andrey%20V.%20Kajava%2C%20Giampietro%20Corradin&start_page=1&end_page=8" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000645" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000645" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0000645" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000645&amp;t=Rapid%20Identification%20of%20Malaria%20Vaccine%20Candidates%20Based%20on%20%CE%B1-Helical%20Coiled%20Coil%20Protein%20Motif" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000645&title=Rapid%20Identification%20of%20Malaria%20Vaccine%20Candidates%20Based%20on%20%CE%B1-Helical%20Coiled%20Coil%20Protein%20Motif&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000645&amp;title=Rapid%20Identification%20of%20Malaria%20Vaccine%20Candidates%20Based%20on%20%CE%B1-Helical%20Coiled%20Coil%20Protein%20Motif" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000645" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0000645&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Rapid Identification of Malaria Vaccine Candidates Based on α-Helical Coiled Coil Protein Motif';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0000645';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Rapid%20Identification%20of%20Malaria%20Vaccine%20Candidates%20Based%20on%20%CE%B1-Helical%20Coiled%20Coil%20Protein%20Motif http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000645" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0000645" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">
















          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Antibodies%22" title="Search for articles in the subject area:'Antibodies'"><div class="flagText">Antibodies</div></a>
              <div data-categoryid="47389" data-articleid="24128"
                   data-categoryname="Antibodies"
                   class="flagImage" title="Flag 'Antibodies' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Enzyme-linked+immunoassays%22" title="Search for articles in the subject area:'Enzyme-linked immunoassays'"><div class="flagText">Enzyme-linked immunoassays</div></a>
              <div data-categoryid="20331" data-articleid="24128"
                   data-categoryname="Enzyme-linked immunoassays"
                   class="flagImage" title="Flag 'Enzyme-linked immunoassays' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Malaria%22" title="Search for articles in the subject area:'Malaria'"><div class="flagText">Malaria</div></a>
              <div data-categoryid="47353" data-articleid="24128"
                   data-categoryname="Malaria"
                   class="flagImage" title="Flag 'Malaria' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Malarial+parasites%22" title="Search for articles in the subject area:'Malarial parasites'"><div class="flagText">Malarial parasites</div></a>
              <div data-categoryid="42885" data-articleid="24128"
                   data-categoryname="Malarial parasites"
                   class="flagImage" title="Flag 'Malarial parasites' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Parasitic+diseases%22" title="Search for articles in the subject area:'Parasitic diseases'"><div class="flagText">Parasitic diseases</div></a>
              <div data-categoryid="2663" data-articleid="24128"
                   data-categoryname="Parasitic diseases"
                   class="flagImage" title="Flag 'Parasitic diseases' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Peptide+synthesis%22" title="Search for articles in the subject area:'Peptide synthesis'"><div class="flagText">Peptide synthesis</div></a>
              <div data-categoryid="40593" data-articleid="24128"
                   data-categoryname="Peptide synthesis"
                   class="flagImage" title="Flag 'Peptide synthesis' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Sequence+motif+analysis%22" title="Search for articles in the subject area:'Sequence motif analysis'"><div class="flagText">Sequence motif analysis</div></a>
              <div data-categoryid="19657" data-articleid="24128"
                   data-categoryname="Sequence motif analysis"
                   class="flagImage" title="Flag 'Sequence motif analysis' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Vaccines%22" title="Search for articles in the subject area:'Vaccines'"><div class="flagText">Vaccines</div></a>
              <div data-categoryid="31861" data-articleid="24128"
                   data-categoryname="Vaccines"
                   class="flagImage" title="Flag 'Vaccines' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=229'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=2767'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=4193&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
